Novo Launches Wegovy Pill In US With Range Of Access Options

 
• By Joseph Haas
  
Novo Nordisk launches the first oral GLP-1 therapy for obesity in the US (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business